eglumetad has been researched along with Disease Models, Animal in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Jin, R; Li, Q; Sun, X; Wu, J; Zhang, S | 1 |
| Borro, M; Caraci, F; Caruso, A; di Nuzzo, L; Mairesse, J; Matrisciano, F; Molinaro, G; Monn, JA; Motolese, M; Nicoletti, F; Nisticò, R; Orlando, R; Pittaluga, A; Scaccianoce, S; Simmaco, M | 1 |
| Cilz, NI; Dong, H; Hu, B; Lei, S; Yang, C; Zhang, H | 1 |
| Barberi, C; Danysz, W; Morè, L; Nagel, J; Pietraszek, M; Schäfer, D; Schlumberger, C; Schmidt, WJ | 1 |
| Krolikowski, KA; Neale, JH; Olszewski, RT; Profaci, CP | 1 |
| Cordeiro, MF; Fitzke, FW; Guo, L; Luong, V; Maass, A; Moss, SE; Salt, TE | 1 |
| Li, W; Neugebauer, V | 1 |
| Bond, A; Hicks, CA; Lodge, D; Monn, JA; O'Neill, MJ | 1 |
| Adams, BW; Moghaddam, B | 1 |
10 other study(ies) available for eglumetad and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Group II metabotropic glutamate receptor agonist promotes retinal ganglion cell survival by reducing neuronal excitotoxicity in a rat chronic ocular hypertension model.
Topics: Animals; Bridged Bicyclo Compounds; Cell Survival; Disease Models, Animal; Excitatory Amino Acid Agonists; Intravitreal Injections; Male; Neurons; Ocular Hypertension; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Retinal Ganglion Cells | 2020 |
Levels of the Rab GDP dissociation inhibitor (GDI) are altered in the prenatal restrain stress mouse model of schizophrenia and are differentially regulated by the mGlu2/3 receptor agonists, LY379268 and LY354740.
Topics: Amino Acids; Animals; Antipsychotic Agents; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cells, Cultured; D-Aspartic Acid; Disease Models, Animal; Epigenesis, Genetic; Female; Guanine Nucleotide Dissociation Inhibitors; Hippocampus; Male; Mice; Pregnancy; Prenatal Exposure Delayed Effects; Proteomics; Receptors, Metabotropic Glutamate; Restraint, Physical; Schizophrenia | 2014 |
Depression of neuronal excitability and epileptic activities by group II metabotropic glutamate receptors in the medial entorhinal cortex.
Topics: Animals; Bridged Bicyclo Compounds; Disease Models, Animal; Entorhinal Cortex; Epilepsy; Excitatory Amino Acid Agonists; Magnesium; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Synaptic Potentials | 2015 |
Effects of a metabotropic glutamate receptor group II agonist LY354740 in animal models of positive schizophrenia symptoms and cognition.
Topics: Animals; Anti-Anxiety Agents; Avoidance Learning; Behavior, Animal; Bridged Bicyclo Compounds; Cognition; Disease Models, Animal; Drug Evaluation, Preclinical; Excitatory Amino Acid Agonists; Exploratory Behavior; Male; Maze Learning; Motor Activity; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Reflex, Startle; Schizophrenia; Schizophrenic Psychology | 2009 |
Group II mGluR agonist LY354740 and NAAG peptidase inhibitor effects on prepulse inhibition in PCP and D-amphetamine models of schizophrenia.
Topics: Animals; Bridged Bicyclo Compounds; Dextroamphetamine; Disease Models, Animal; Dose-Response Relationship, Drug; Excitatory Amino Acid Agonists; Glutamate Carboxypeptidase II; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Organophosphorus Compounds; Phencyclidine; Receptors, Metabotropic Glutamate; Reflex, Startle; Schizophrenia; Species Specificity; Urea | 2011 |
Assessment of neuroprotective effects of glutamate modulation on glaucoma-related retinal ganglion cell apoptosis in vivo.
Topics: Animals; Apoptosis; Bridged Bicyclo Compounds; Disease Models, Animal; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Therapy, Combination; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Glaucoma; Glutamic Acid; Intraocular Pressure; Male; Neuroprotective Agents; Ocular Hypertension; Piperidines; Rats; Receptors, Metabotropic Glutamate; Receptors, N-Methyl-D-Aspartate; Retinal Ganglion Cells; Staurosporine | 2006 |
Differential changes of group II and group III mGluR function in central amygdala neurons in a model of arthritic pain.
Topics: Alanine; Aminobutyrates; Amygdala; Animals; Arthritis; Bridged Bicyclo Compounds; Disease Models, Animal; Excitatory Amino Acid Agonists; Glutamates; Male; Neuronal Plasticity; Nociceptors; Pain; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Synaptic Transmission | 2006 |
Neuroprotective effects of a systemically active group II metabotropic glutamate receptor agonist LY354740 in a gerbil model of global ischaemia.
Topics: Animals; Brain Ischemia; Bridged Bicyclo Compounds; Disease Models, Animal; Excitatory Amino Acid Agonists; Gerbillinae; Male; Neuroprotective Agents; Receptors, Metabotropic Glutamate | 1998 |
Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats.
Topics: Animals; Bridged Bicyclo Compounds; Disease Models, Animal; Dopamine; Excitatory Amino Acid Agonists; Glutamic Acid; Male; Memory; Motor Activity; Nucleus Accumbens; Phencyclidine; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Schizophrenia; Stereotyped Behavior; Synaptic Transmission | 1998 |